ConductScience.org, home

Library / Genes

MAG: myelin associated glycoprotein

1 protein, 69 patents, 1 drug, 2 trials, 2,343 NIH grants and 4,594 papers.

Gene 7

Its symbol and name are HGNC's, unless HGNC and NCBI Gene contradict each other.

FieldValueSource
SymbolMAGHGNC
Namemyelin associated glycoproteinHGNC
NCBI Gene ID4099NCBI Gene
HGNC IDHGNC:6783HGNC
EnsemblENSG00000105695NCBI Gene
AliasesGMA, S-MAG, SIGLEC-4A, SIGLEC4, SIGLEC4A, SPG75NCBI Gene
Typeprotein-codingNCBI Gene

Proteins 1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated inSource
P20916Myelin-associated glycoprotein6260Ensembl, GeneID, HGNCUniProt

Patents 69

Patents whose sequence listing holds the protein exactly: the same sequence, by SHA-256, length and CRC-64. A sequence a patent lists is not always one it claims.

PublicationPublishedSEQ ID NOProteinSource
JP 2026004568 A2026-01-1454267P20916Espacenet
EP 4650780 A22025-11-1910902P20916Espacenet
EP 4641201 A22025-10-2911278P20916Espacenet
JP 2025156500 A2025-10-144P20916Espacenet
JP 2025147176 A2025-10-068268P20916Espacenet
JP 2025531671 A2025-09-2523P20916Espacenet
JP 2025529142 A2025-09-042514P20916Espacenet
JP 2025529142 A2025-09-046967P20916Espacenet
US 12371689 B22025-07-292514P20916Espacenet
US 12371689 B22025-07-296967P20916Espacenet

Drugs 1

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

DrugChEMBL IDMechanismActionSource
REFANEZUMABCHEMBL3545317Myelin-associated glycoprotein inhibitorINHIBITORChEMBL

Trials 2

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

TrialDrugPhaseResults first postedSource
NCT01808261REFANEZUMABPHASE22017-10-03ClinicalTrials.gov
NCT00833989REFANEZUMABPHASE22017-10-16ClinicalTrials.gov

NIH grants 2343

NIH projects whose papers are about the gene, through NIH's grant-paper links.

ProjectTitleIts papers about the geneNewest fiscal yearSource
P50CA186781Mayo Clinic Multiple Myeloma SPORE142,025NIH's project files
P30CA010815Consolidated Basic Cancer Research Program92,025NIH's project files
P30CA016672Cancer Center Support Grant82,025NIH's project files
P30DK058404Molecular and Cellular Basis for Digestive Diseases72,025NIH's project files
P30CA008748Cancer Center Support Grant62,025NIH's project files
R01AA011431FASD Inhibition of ASPH-Notch Mediates Adolescent Cerebral White Matter Pathology-Potential Utility of Non-invasive Extracellular Vesicle Assays62,025NIH's project files
R28AA012725Brain Tissue Resource Center for Alcohol Research62,025NIH's project files
UL1TR001863Yale Clinical and Translational Science Award52,025NIH's project files
P30CA013330Cancer Center Support Grant42,025NIH's project files
P30CA013696Cancer Center Support Grant42,025NIH's project files

Papers 4594

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

PMIDFound bySource
42814674PubTator, text miningPubMed
42813697PubTator, text miningPubMed
42783271PubTator, text miningPubMed
42767155PubTator, text miningPubMed
42692266PubTator, text miningPubMed
42657436PubTator, text miningPubMed
42647286PubTator, text miningPubMed
42570342PubTator, text miningPubMed
42460638PubTator, text miningPubMed
42396941PubTator, text miningPubMed

The same record as JSON

Release gene-search-2026-11-11-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ChEMBL, through Open Targets: CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

EMBL-EBI's patent proteins: EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use

GenBank's patent files: GenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/

HGNC: CC0: https://www.genenames.org/about/license/

NCBI Gene: None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/

NIH's project files and grant-paper links: Public domain (NIH RePORTER)

Open Targets: CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

PubTator 3: Public domain

UniProt: CC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license